Gregory L. Skuta, MD, has been named president and chief executive officer (CEO) of the Dean McGee Eye Institute, succeeding David W. Parke II, MD, who was appointed executive vice president and CEO of the American Academy of Ophthalmology in San Francisco in 2009.
Tom Hejkal, MD, PhD, became the McGaw Memorial Chairman of the Department of Ophthalmology and Visual Sciences at University of Nebraska Medical Center on Dec. 1.
ISTA Pharmaceuticals Inc. has submitted a supplemental new drug application to the FDA for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery.
Bausch & Lomb has announced the launch of the first aberration-free accommodating IOL with aspheric optics (Crystalens AO) to cataract surgeons worldwide.
Alcon Laboratories Inc. plans to acquire Optonol Ltd. by the end of first quarter.
TLC Vision Corp. and two of its wholly owned subsidiaries, TLC Vision (USA) Corp. and TLC Management Services, are restructuring their debt through a pre-arranged Chapter 11 bankruptcy proceeding.
Novartis AG has exercised its option to purchase the remaining shares in Alcon Laboratories Inc. owned by Nestle S.A. at a weighted average price of $180 per share in cash, according to prepared statement from Alcon.
An angle-supported phakic lens had a minimal effect on corneal endothelial cell health in patients followed up to 4 years after implantation.
A microkeratome is a safe and effective alternative to femtosecond laser for flap creation when performing sub-Bowman's keratomileusis, and the mechanical device offers a number of advantages as well.
The latest version of an accommodating IOL provides increased depth of field for better near vision performance than predecessor versions.
With this issue of Ophthalmology Times, the publication launches a new series that will feature different institutions around the country.
Preliminary results from a study investigating use of a intraoperative wavefront aberrometer indicate that it accurately measures the refraction in aphakic eyes and translates the data into IOL power to enable excellent outcomes after cataract surgery.
A corneal inlay improves near and intermediate vision without compromising functional distance vision.
A refractive procedure 15 years in the making uses microwave technology to reshape the cornea.
After decades of giving pharmaceutical treatment options for glaucoma, Alcon Laboratories plans to add a surgical treatment option by acquiring Optonol Ltd.
Accumulating results from studies investigating a light-adjustable IOL indicate this technology can afford precise postoperative control over refractive outcomes.
Early results are encouraging using the 500 kHz femtosecond laser in a reverse-cut technique to prepare DSEK donor tissue.
When first treating patients with acute chemical burns of the eye, one expert advises use of a buffering solution for irrigation rather than isotonic saline.
Accumulating results from studies investigating a light-adjustable IOL indicate this technology can afford precise postoperative control over refractive outcomes
A monofocal hydrophilic acrylic IOL with a square-edge design has high capsular biocompatibility
Ad advanced LASIK procedure provides excellent visual outcomes, night vision, and overall quality of vision.
Accurate biometry, accurate keratometry, use of both an appropriate IOL power calculation formula and personalized A-constant, and the elimination of astigmatism all are essential factors for obtaining a good refractive result following cataract surgery in eyes with a history of keratorefractive surgery.
For me, 2009 will go down as a year of disappointment.
An angle-supported phakic lens had a minimal effect on corneal endothelial cell health in patients followed up to 4 years after implantation.
Wavefront-optimized PRK performed off-label with a 400-Hz excimer laser produced excellent safety and visual outcomes.
Comparing a refractive multifocal IOL with a diffractive multifocal IOL showed that the diffractive multifocal lens provides excellent intermediate visual acuity despite theoretical predictions to the contrary.
Although Descemet's membrane endothelial keratoplasty represents the ideal of pure anatomic replacement surgery, results of a laboratory study indicate the procedure is still in an early stage of development.
Many men Dr. McDonnell's age become attached to certain items of clothing.
The past year saw a continuation of developments and refinements of refractive surgery technologies.
When Joseph J. Sokol, MD, decided to break out on his own about a year ago, one of his first major decisions was choosing an electronic medical record company.
.png "Optometry Times"){kind=logo}
